Tuesday, December 18, 2018

Injection Improves Vision in a Form of Childhood Blindness

(c) NIH
A new treatment for patients with a form of congenital retinal blindness has shown success in improving vision, according to results published today in Nature Medicine led by researchers at the Scheie Eye Institute  in the Perelman School of Medicine at the University of Pennsylvania.

Wednesday, December 12, 2018

Tuesday, December 4, 2018

Detecting prions in eyes of patients with Creutzfeldt-Jakob disease

(c) NIH
Prions are abnormal forms of natural proteins. The misshapen proteins collect in brain tissue and cause cells to die, leaving sponge-like holes in the brain. Prion diseases include “mad cow” disease in cattle and Creutzfeldt-Jakob disease (CJD) in people. People can get CJD by eating infected beef, but most cases develop spontaneously. This rare disease, which affects about one in a million people, is untreatable and fatal.

Monday, December 3, 2018

A novel drug for treatment of diabetic retinopathy

(c) Centenary Institute, Sydney, Australia
Scientists at the Centenary Institute have developed a novel drug which could potentially be used to effectively treat patients with diabetic retinopathy.

Diabetic retinopathy often occurs in diabetic patients, even when their blood sugar levels are controlled. In diabetic retinopathy, the tiny blood vessels in the retina are damaged and can leak fluid or haemorrhage, often leading to vision loss.

Wednesday, November 28, 2018

Minimally invasive retinal detachment treatment offers patients better outcomes

(c) Mayo Clinic
A minimally invasive treatment for retinal detachment gives patients sharper vision, less distortion and reduced side-effects, according to the findings of a randomized controlled trial. The findings have been published in Ophthalmology, the journal of the American Academy of Ophthalmology.

Why screen time on digital devices such as computers and phones disrupt sleep?

(c) Salk Institute
For most, the time spent staring at screens—on computers, phones, iPads—constitutes many hours and can often disrupt sleep. Now, Salk Institute researchers have pinpointed how certain cells in the eye process ambient light and reset our internal clocks, the daily cycles of physiological processes known as the circadian rhythm. When these cells are exposed to artificial light late into the night, our internal clocks can get confused, resulting in a host of health issues.

Sunday, March 25, 2018

LCA patients gain benefit from Spark Therapeutics' gene therapy treatment, Luxturna

(c) Mass Eye & Ear
With the approval of Spark Therapeutics' Luxturna for Leber's Congenital Amaurosis (LCA), eye institutions around the US have started offering the treatment to their patients. In recent days, we have heard of this treatment being offered for the first time after the approval in Massachusetts Eye and Ear in Boston, followed the same day by the Children's Hospital of Los Angeles. A few days later, Bascom Palmer Eye Institute completed its first case.